Recruiting EARLY_PHASE1 INTERVENTIONAL 3-arm NCT06326684

Suvorexant and Alcohol

Influence of Orexin Antagonism on Motivation for Alcohol

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Interventions Alcohol Placebo Suvorexant

Updated 7 times since 2024 Last updated: Dec 20, 2025 Started: Jun 7, 2024 Primary completion: Mar 15, 2027 Completion: Mar 15, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06326684, this EARLY_PHASE1 trial focuses on Alcohol Use Disorder and remains actively recruiting participants. Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), it has been updated 7 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Recruiting EARLY_PHASE1
Jul 2025 — Jan 2026 [monthly]

Recruiting EARLY_PHASE1
Jan 2025 — Jul 2025 [monthly]

Recruiting EARLY_PHASE1
Sep 2024 — Jan 2025 [monthly]

Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jun 2024 — Jul 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1
Apr 2024 — Jun 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
William Stoops

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States